GeraldDrydenMDPhD, MSPH, MSc
Gastroenterology • Louisville, KYAdvanced Endoscopic Interventional, Inflammatory Bowel Disease
Professor of Medicine and Bioengineering, University of Louisville
Dr. Dryden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 E Chestnut St
Suite 310
Louisville, KY 40202Phone+1 502-584-8563Fax+1 502-562-6196- Is this information wrong?
Clinical Expertise
- Inflammatory bowel disease, Ulcerative colitis, Crohn's disease, Esophageal disease, Celiac disease, Esophagoscopy, Upper GI Endoscopy, Colon cancer, Medical device design
Education & Training
University of LouisvillePhD, Microbiology and Immunology, 2016- University of LouisvilleMSPH, Clinical Investigation, 2003
Naval Medical Center (San Diego)Fellowship, Gastroenterology, 1995 - 1997
Naval Medical Center (Portsmouth)Residency, Internal Medicine, 1992 - 1995
University of Kentucky College of MedicineClass of 1992
Certifications & Licensure
KY State Medical License 1998 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2011
- Fellow (ASGE) American Society of Gastrointestinal Endoscopy, 2010
Clinical Trials
- Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis Start of enrollment: 2008 Mar 01
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- P027 Brain Fog in Patients With Inflammatory Bowel Disease, and Association With Use of Probiotics.Apaar Dadlani, Khushboo Gala, Jayesh Rai, Shesh Rai, Gerald Dryden> ;The American Journal of Gastroenterology. 2021 Dec 1
- 43 citationsEtrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.David T. Rubin, Iris Dotan, Aaron DuVall, Yoram Bouhnik, Graham L. Radford-Smith, Peter D R Higgins, Daniel S Mishkin, Pablo Arrisi, Astrid Scalori, Young S Oh, Swati ...> ;The Lancet. Gastroenterology & Hepatology. 2021 Nov 16
- 41 citationsEtrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, ran...Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez, Pascal Juillerat, A. Armuzzi, Edward V Loftus, Elham Ostad-Saffari, Astrid Scalori,...> ;The Lancet. Gastroenterology & Hepatology. 2021 Nov 17
- Join now to see all
Press Mentions
UofL and Robley Rex VA Medical Center Partnership Leads to New State-of-the-Art Multiphoton Microscopes for Exposure StudiesNovember 22nd, 2022- Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease PatientsJuly 26th, 2021
uBiome Launches Research Partnership with University of Louisville Physicians to Investigate the Microbiome as a Predictor of Clinical Response to IBD TherapiesMarch 7th, 2019- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
UofL Health - Jewish HospitalLouisville, Kentucky- Norton Audubon HospitalLouisville, Kentucky
Norton HospitalLouisville, Kentucky
Robley Rex Department of Veterans Affairs Medical CenterLouisville, Kentucky
UofL Health - UofL HospitalLouisville, Kentucky
Norton Children's HospitalLouisville, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
